Table 1.
Correlation between expression of annexin A7 and clinicopathological factors of GC tissues
| Characteristic | Negative annexin A7 (n=56) | Positive annexin A7 (n=106) | P value |
|---|---|---|---|
| Age (yr.) | 0.767 | ||
| < 60 | 23 (41.1%) | 41 (38.7) | |
| ≥ 60 | 33 (58.9) | 65 (61.3) | |
| Gender distribution | 0.536 | ||
| male | 42 (75.0) | 84 (79.2) | |
| female | 14 (25.0) | 22 (20.8) | |
| Differentiation | 0.018 | ||
| well | 4 (7.1) | 3 (2.8) | |
| moderate | 22 (39.3) | 23 (21.7) | |
| poor | 30 (53.6) | 80 (75.5) | |
| Pathological stage | 0.042 | ||
| I | 15 (26.8) | 15 (14.2) | |
| II | 14 (25.0) | 17 (16.0) | |
| III | 24 (42.9) | 60 (56.6) | |
| IV | 3 (5.4) | 14 (13.2) | |
| Submucosal confinement | 0.047 | ||
| early | 10 (17.9) | 8 (7.5) | |
| advanced | 46 (82.1) | 98 (92.5) | |
| Lymph node involvement | 0.047 | ||
| PN 0 | 6 (10.7) | 18 (16.1) | |
| PN 1-2 | 24 (42.9) | 27 (24.1) | |
| PN 3a-3b | 26 (46.4) | 61 (59.8) | |
| Tumor size | 0.188 | ||
| < 5 | 15 (26.8) | 19 (17.9) | |
| ≥ 5 | 41 (73.2) | 87 (82.1) |